Update on the pathologic diagnosis of malignant mesothelioma

被引：10
作者：
Schulte, Jefree J. [1 ]
Husain, Aliya N. [1 ]
机构：
[1] Univ Chicago, Dept Pathol, 5841 S Maryland,MC6101, Chicago, IL 60637 USA
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2020年 / 9卷 / 03期
关键词：
Malignant mesothelioma; nuclear grading; BAP1; MTAP; mesothelioma in situ; BAP1; IMMUNOHISTOCHEMISTRY; PLEURAL MESOTHELIOMA; CONSENSUS STATEMENT; BRCA1-ASSOCIATED PROTEIN-1; EFFUSION CYTOLOGY; P16; FISH; EXPRESSION; LUNG; GUIDELINES; MARKER;
D O I：
10.21037/tlcr-19-620
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Malignant mesothelioma is an uncommon tumor that may be difficult to diagnose. The International Mesothelioma Interest Group has been writing guidelines for pathological diagnosis that are periodically updated. The guidelines are being updated based on published literature in the last 3 years, and experience of more than 20 leading international pathologists in the field who will be co-authors. Updates were discussed by attendees of the Pulmonary Pathology Society Biennial Meeting (Dubrovnik, Croatia, June 2019). Areas with significant advancements/changes include utilization of immunohistochemistry (establishing mesothelial lineage and benign versus malignant), prognosis and nuclear grading, biphasic malignant mesothelioma, transitional pattern, malignant mesothelioma in situ, and therapeutic/molecular targets.
引用
收藏
页码：917 / 923
页数：7
相关论文
共 47 条
  • [1] MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma
    Amatya, Vishwa Jeet
    Kushitani, Kei
    Mawas, Amany Sayed
    Miyata, Yoshihiro
    Okada, Morihito
    Kishimoto, Takumi
    Inai, Kouki
    Takeshima, Yukio
    [J]. MODERN PATHOLOGY, 2017, 30 (05) : 672 - 681
  • [2] Anderson T, 2015, AM J SURG PATHOL, V39, P132, DOI 10.1097/PAS.0000000000000346
  • [3] Molecular Characterization of Inflammatory Myofibroblastic Tumors With Frequent ALK and ROS1 Gene Fusions and Rare Novel RET Rearrangement
    Antonescu, Cristina R.
    Suurmeijer, Albert J. H.
    Zhang, Lei
    Sung, Yun-Shao
    Jungbluth, Achim A.
    Travis, William D.
    Al-Ahmadie, Hikmat
    Fletcher, Christopher D. M.
    Alaggio, Rita
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (07) : 957 - 967
  • [4] Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas
    Berg, Kyra B.
    Dacic, Sanja
    Miller, Caitlyn
    Cheung, Simon
    Churg, Andrew
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (12) : 1549 - 1553
  • [5] GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung
    Berg, Kyra B.
    Churg, Andrew
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (09) : 1221 - 1225
  • [6] Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping
    Brcic, Luka
    Vlacic, Gregor
    Quehenberger, Franz
    Kern, Izidor
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (06) : 747 - 752
  • [7] BAP1 and cancer
    Carbone, Michele
    Yang, Haining
    Pass, Harvey I.
    Krausz, Thomas
    Testa, Joseph R.
    Gaudino, Giovanni
    [J]. NATURE REVIEWS CANCER, 2013, 13 (03) : 153 - 159
  • [8] Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma
    Chaouche-Mazouni, Siham
    Scherpereel, Arnaud
    Zaamoum, Rima
    Mihalache, Adriana
    Arnir, Zine-Charaf
    Lebaili, Nemcha
    Delaire, Baptiste
    Gosset, Pierre
    [J]. ANNALS OF DIAGNOSTIC PATHOLOGY, 2015, 19 (04) : 193 - 197
  • [9] MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma
    Chapel, David B.
    Schulte, Jefree J.
    Berg, Kyra
    Churg, Andrew
    Dacic, Sanja
    Fitzpatrick, Carrie
    Galateau-Salle, Francoise
    Hiroshima, Kenzo
    Krausz, Thomas
    Le Stang, Nolwenn
    McGregor, Stephanie
    Nabeshima, Kazuki
    Husain, Aliya N.
    [J]. MODERN PATHOLOGY, 2020, 33 (02) : 245 - 254
  • [10] Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group
    Chapel, David B.
    Churg, Andrew
    Santoni-Rugiu, Eric
    Tsujimura, Tohru
    Hiroshima, Kenzo
    Husain, Aliya N.
    [J]. LUNG CANCER, 2019, 127 : 69 - 75
12345